Future Table of Contents


Future Table of Contents

Volume 24, Number 4

Ovarian Function Following Chemotherapy Among Young Breast Cancer Survivors
K. Morarji, O. McArdle, K. Hui, G. Gingras-Hill, S. Ahmed, E.M. Greenblatt, E. Warner, S. Sridhar, A.M.F. Ali, A. Azad, D.C. Hodgson

Extrahepatic Metastasis of Hepatocellular Carcinoma Arising from a Hepatic Adenoma Without Concurrent Intrahepatic Recurrence
N. Poddar, R. Ramlal, S. Ravulapati, S. M Devlin, S. Gadani, C.I. Vidal, D. Cao, A.S. Befeler, J. Lai

Patterns of spread and prognostic implications of lung cancer metastases: a population-based study in an era of driver mutations
F. Hsu, A. De Caluwe, D. Anderson, T. Toriumi, A. Nichol, C. Ho

Clinical results of accelerated hypofractionated radiotherapy for small central lung tumors
Y. Hatayama

An analysis of Nanny Angel Network (NAN) and the benefits of free childcare for mothers diagnosed with cancer
L. Cohen, N. Schwartz, A. Guth, A. Kiss, E. Warner

Phase II trial of dose reduced capecitabine in elderly patients with advanced colorectal cancer
M.D. Vincent, D.A. Breader, C. Cripps, D.J. Jonker, P. Klimo, J.J. Biagi, W. Lam, A. O'Connell, F. Whiston, L. Stitt, S.A. Welch

Exercise for people with cancer: a systematic review
R. Segal, C. Zwaal, E. Green, J. Tomasone, A. Loblaw, T. Petrella

Canadian Oncologists Experiences with Difficult Patient Deaths and Coping Strategies
L. Granek

Communication and Informed Consensus....A Story
E. Aitini

Adrenocortical Carcinoma; 40-year experience of a Canadian Tertiary Cancer Centre
S. Atallah, H. Al-assaf, Y. Xu, S. El-Sayed

Oral Chinese Herbal Medicine as Maintenance Treatment after Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Systemic Review and Meta-Analysis
Q. Wang, Q. Wang, S. Wang, L. Jiao, R. Zhang, Y. Zhong, J. Zhang, L. Xu

Real-life treatment of metastatic colorectal cancer with regorafenib: a single-centre review
J. Gotfrit, M. Vickers, S. Sud, T. Asmis, C. Cripps, R. Goel, T. Hsu, D. Jonker, R. Goodwin

Pomalidomide Desensitization in a Patient Hypersensitive to Immunomodulating agents
J. Seki

Countercurrents: Women with Cancer in the Developing World
S.A. Narod

Reporting lymph node retrieval rates in melanoma: Validating a quality assessment parameter
D. Berger-Richardson

Treatment patterns and trends of patients dying of prostate cancer in Quebec: a population-based study
A. Dragomir

Commentary: Wherein the Authors Attempt to Minimise the Confusion Generated by their Study “Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ” by Several Commentators who Disagree with Them and a Few who Don’t: a Qualitative Study
S.A. Narod

Systemic Therapy of Incurable Gastroenteropancreatic Neuroendocrine Tumours: A Clinical Practice Guideline
S. Singh, D. Sivajohanathan, T. Asmis, C. Cho, N. Hammad, C. Law, R. Wong, K. Zbuk

Meeting Report: The Canadian Lung Cancer Conference 2017
N. Chooback

When the Patient is also a Carer
E. Warner

American Society of Clinical Oncology 2017 Meeting Summary: Updates to practice changing studies in untreated non-Hodgkin lymphoma
P. Laneuville, J.-F. Larouche, A. Tosikyan, A. Christofides

Upcoming in Current Oncology

A systematic review and network meta-analysis of post-imatinib therapy in advanced gastrointestinal stromal tumour
K. Shah

Orbital mass as first presentation of metastatic p16+ oropharyngeal squamous cell carcinoma
J. Corbett, D. Wilke, J. Trites, N. Lamond

Feasibility of Assessing Patient Health Benefits and Incurred Costs from Early Dysphagia Intervention during and immediately following Chemoradiotherapy for Head and Neck Cancer
R. Martino, J. Ringash, L. Durkin, E. Greco, S. Hui-Huang, W. Xu, C. Longo

Training Oncoplastic Breast Surgeons: Where Does Canada Stand?
J. Maxwell, A. Aranaout, R. Hanrahan, M. Brackstone

Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex due to a TSC2 deletion – a case report
M. Niedziela

Neoadjuvant systemic therapy in breast cancer; utilization and radiotherapy practice trends
T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson

Short course Lenalidomide plus Low Dose Dexamethasone in Treatment of Newly Diagnosed Multiple Myeloma – Single Center study
W.M. Jose, P. Keechilat, G.S. Trivadi

Conditional survival after diagnosis with malignant brain tumour in Canada: 2000-2008
Y. Yuan, J. Ross, Q. Shi, F. Davis

The Effects of the Community-Based, Wellspring Cancer-Exercise Program on Functional and Psychosocial Outcomes in Cancer Survivors
D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell

A case of metastatic prostate cancer and immune thrombocytopenia
D. Betsch, S. Gray, S.E. Zed

The clinical significance of occult gynecologic primary tumours in metastatic cancer
M.B. Hannouf, E. Winquist, S.M. Mahmud, M. Brackstone, S.S. Sarma, G. Rodrigues, P.K. Rogan, J.S. Hoch

Clinical Utility of Multigene Profiling Assays in Early-Stage Breast Cancer
M.C. Chang, L.H. Souter, S. Kamel-Reid, M. Rutherford, P. Bedard, M. Trudeau, J. Hart, A. Eisen

Cost analysis of breast cancer diagnostic assessment programs
G.N. Honein-AbouHaidar, J.S. Hoch, M.J. Dobrow, T. Stuart-McEwan, D.R. McCready, A.R. Gagliardi

Lung cancer care trajectory at a Canadian Centre: an evaluation of wait times effect on clinical outcomes
G. Kasymjanova, D. Small, T.R. Jagoe, G. Batist, W. Sateren, P. Ernst, C. Pepe, L. Sakr, V. Cohen, J. Agulnik

Understanding quality of evidence in survivorship care plans for Breast Cancer patients: should we expect standardized plans across jurisdictions?
V. D'Souza, H. Daudt, A. Kazanjian

The impact of pCODR on cancer drug funding decisions
A. Srikanthan, H. Mai, N. Penner, E. Amir, A. Laupacis, M. Sabharwal, K. Chan

Wait times for diagnosis and treatment of lung cancer: a single centre experience
C. Labbé

Development of an online, patient-centered decision aid for patients with oropharyngeal cancer in the transoral robotic surgery era
J.S. Lam, G.M. Scott, D.A. Palma, K. Fung, A.V. Louie

What we learned in kindergarten: 5 tips for collaboration in oncology
A. Arnaout

Shifting practice in definitive chemoradiation for localized esophageal cancer
X.M. Qu, J.J. Biagi, W.M. Hopman, A. Mahmud

Framingham Risk Score underestimates risk of cardiovascular events in HER2+ breast cancer population
W. Law, C. Johnson, M. Rushton, S. Dent

Reasons for no systemic therapy in stage IV NSCLC: comparison of years 2003-2006 vs. 2010-2011
J. Jaeeun K

Breast cancer and dermatomyositis: a case study and literature review
E.M. Hendren

An evaluation of the physical activity information and support posted on cancer centre websites for breast cancer survivors
C. Sabiston

The Views of Patients with Brain Cancer on Palliative Care: A Qualitative Study
M.J. Vierhout, M. Daniels, P. Mazzotta, J. Vlahos, W.P. Mason, M. Bernstein

Risk and predictors of suicide in colorectal cancer patients: A SEER analysis
H.H. Samawi, A.A. Shaheen, P.A. Tang, D.Y.C. Heng, W.Y. Cheung, M.M. Vickers

A Mighty Khatun
S. Lalani

Irreversible Tyrosine Kinase Inhibition of EGFR with Afatinib in EGFR mutation-positive Advanced Non-Small Cell Lung Cancer
S. Morin-Ben Abdallah, V. Hirsh

Staging and Surgical Approaches in Gastric Cancer: A Clinical Practice Guideline
N. Coburn, R. Cosby, L. Klein, G. Knight, R. Malthaner, J. Mamazza, C.D, Mercer, J, Ringash

The Predictive Impact of Primary Tumour Location in the Treatment of Metastatic Colorectal Cancer: A Canadian Consensus Statemen
S, Karim, A, Abrahao, B, Colwell, S, Berry, J, Biagi